Back to Headlines
Health
Jun 18, 2026
Analyzed by Llama- 4 Scout 17B 16E Instruct

HPV Vaccine Cuts Cervical Cancer Deaths to Almost Zero in Women Under 30

AI Summary
A groundbreaking study finds that women who received the HPV vaccine in early adolescence have virtually zero risk of dying from cervical cancer before age 30. The vaccine has saved hundreds of lives in England, but falling vaccination rates could lead to a rise in avoidable deaths.

The Impact of HPV Vaccination on Cervical Cancer Mortality

Women who received an HPV vaccine in early adolescence have virtually zero risk of dying from cervical cancer before the age of 30, according to a groundbreaking study. However, falling vaccination rates could see a rise in avoidable deaths.

Cervical Cancer Statistics and HPV Vaccine Effectiveness

Cervical cancer is the fourth most common cancer in women, according to the World Health Organization, and high-risk human papillomaviruses (HPV) cause 99% of cases. About 3,300 women in England are diagnosed with the disease every year. The HPV vaccine prevents about 90% of cervical cancers.

The Data Analysis: Mortality Rates and Vaccination Impact

Researchers from Queen Mary University of London used official cancer mortality and vaccination data for women aged 20 to 34 to calculate the impact of vaccination on cervical cancer survival. The study, funded by Cancer Research UK and published in the Lancet, saw substantial falls in cervical cancer mortality in those who were offered vaccination after the HPV jab was introduced in 2008.

The Impact Analysis: HPV Vaccination and Cervical Cancer Prevention

The likelihood of girls who are inoculated when they are 12 or 13 dying from cervical cancer before the age of 30 is almost zero. For vaccinated women aged 30-34, the relative risk of death from the disease is 63% lower. For the first time in recorded history, no women aged 20 to 24 died from cervical cancer in England between 2020 and 2024.

The Prediction: Future Outlook and Concerns

Despite the success of the HPV vaccine, falling vaccination rates could lead to a rise in avoidable deaths. The WHO’s global strategy on cervical cancer states that by 2030, all countries should vaccinate 90% of girls with the HPV vaccine by the age of 15, screen 70% of women and treat 90% of those with cervical disease. However, vaccination rates have fallen significantly since the pandemic, and experts warn that without swift and concerted efforts to increase HPV vaccine uptake, there could be another 15-25 avoidable deaths each year in young women and eventually about 200 deaths from cervical cancer each year that could be prevented.